Delivery Order SPE2DB22D9316-SPE2DB25FYM59

Award Date 11/14/24
Potential Completion Date 12/6/24
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $14,418.03 contract is for the delivery of 4,568,383,013 units of the pharmaceutical product CEREZYME 400 UNIT VIALS, with a completion date of June 3, 2025. DMS Pharmaceutical Group Inc. is an established federal contractor, holding a $499,999,999 Indefinite Delivery Contract (IDC) with DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,881.60, is for the delivery of CEREZYME 400 UNIT VIALS to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with DLA under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,313.60, is for the delivery of CEREZYME 400 unit vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a significant single-award indefinite delivery contract (IDC) with the DLA, valued at up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,449.60 firm fixed-price contract is for the supply of CEREZYME 400 unit vials, with an ultimate completion date of October 3, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,418.03, is for the delivery of CEREZYME 400 UNIT VIALS, a specialized pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc., valued at $499,999,999 and valid through November 2026. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $14,418.03 and covers the delivery of CEREZYME 400 UNIT VIALS to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a diverse array of branded and generic prescription...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $13,136.00 contract is for the delivery of CEREZYME 400 UNIT VIALS, a pharmaceutical product, with a completion date of February 27, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA, valued up to $4,999,999 through 2025, for a broad range of pharmaceutical...
This is a firm fixed-price delivery order worth $7,881.60 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the delivery of 400-unit vials of the pharmaceutical product Cerezyme and has a completion date of May 20, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to...
This federal contract award is a delivery order worth $14,418.03 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4,568,679,372 units of CEREZYME 400 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of July 15, 2025 and was awarded on June 23, 2025 under a firm fixed-price arrangement. DMS Pharmaceutical Group Inc. has a significant...
This is a $22,471.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Cerezyme 400 unit vials, with a performance period through November 26, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB25FYM59
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $7,881.60 contract is for the delivery of 4,566,545,300 units of the pharmaceutical product CEREZYME 400 UNIT VIALS. The contract has an ultimate completion date of December 6, 2024 and is not associated with a set-aside designation.

DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. This delivery order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA, which enables the agency to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical products.

Generated 2/13/25, 9:03 AM